It's either the “sink hypothesis” is wrong or they are missing something so it is not complete. But in any case, I think the “sink hypothesis” has been discredited by the latest Solanezumab data.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.